TCEAL7, a putative tumor suppressor gene, negatively regulates NF-κB pathway
Open Access
- 7 December 2009
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 29 (9) , 1362-1373
Abstract
We have previously shown that a frequently downregulated gene, transcription elongation factor A-like 7 (TCEAL7), promoted anchorage-independent growth and modulated Myc activity in ovarian surface epithelial cells immortalized with temperature-sensitive large T antigen and human telomerase reverse transcriptase (OSEtsT/hTERT). Analysis of protein/DNA array showed that TCEAL7 downregulation resulted in an approximately twofold increase in nuclear factor (NF)-κB binding to its target DNA sequence. In this study we showed that short hairpin RNA (shRNA)-mediated downregulation of TCEAL7 in two different immortalized OSE cells showed higher NF-κB activity, as determined using reporter and gel-shift assays. Transient transfection of TCEAL7 inhibited the activation of NF-κB in TCEAL7-downregulated clones, IOSE-523 and in other ovarian cancer cell lines (OVCAR8, SKOV3ip and DOV13), suggesting that TCEAL7 negatively regulates NF-κB pathway. Consistent with this observation, TCEAL7-downregulated clones showed higher levels of NF-κB targets, such as pro-proliferative (cyclin-D1 and cMyc), pro-angiogenic (interleukin (IL)-6, IL-8 and vascular endothelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxygenase-2 (Cox-2)) and anti-apoptotic (B-cell lymphoma-extra large (Bcl-xl)) genes when compared with vector controls. Inhibition of NF-κB by IκB kinase (IKK) inhibitor (BMS 345541) attenuated cell survival and proliferation of TCEAL-knockdown clones. Although TCEAL7 inhibited p65 transcriptional activity, it did not modulate the cytoplasmic signaling of the NF-κB pathway, by itself or by tumor necrosis factor-α (TNF-α). Chromatin immunoprecipitation (ChIP) assays revealed increased recruitment of p65 and p300 to the promoters of IL-8 and IL-6 in TCEAL7-downregulated clones. Collectively, these results indicate a novel role for TCEAL7 in the negative regulation of NF-κB signaling at the basal level by modulating transcriptional activity of NF-κB on its target gene promoters, potentially providing a novel mechanism by which NF-κB activity may be deregulated in ovarian cancer cells.Keywords
This publication has 29 references indexed in Scilit:
- Metformin Attenuated the Autoimmune Disease of the Central Nervous System in Animal Models of Multiple SclerosisThe Journal of Immunology, 2009
- A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformationOncogene, 2008
- The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectinJournal of Clinical Investigation, 2008
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent diseaseGynecologic Oncology, 2005
- NFkB-dependent chemoresistance in solid tumorsInt. Journal of Clinical Pharmacology and Therapeutics, 2002
- Galactosylsphingosine (psychosine) ‐induced expression of cytokine‐mediated inducible nitric oxide synthases via AP‐1 and C/EBP: implications for Krabbe diseaseThe FASEB Journal, 2002
- Structure-Function Analysis of NADEJournal of Biological Chemistry, 2002
- Soluble intercellular adhesion molecule—1 (ICAM-1) is released into the serum and ascites of human ovarian carcinoma patients and in nude mice bearing tumour xenograftsEuropean Journal of Cancer, 1994
- Characterization of Three Abundant mRNAs from Human Ovarian Granulosa CellsDNA and Cell Biology, 1990